While new manufacturing technologies have the potentially to dramatically shift the way the pharmaceutical industry works, many challenges are preventing wider adoption.

In this commentary article, we present Axel Becker's insights on the latest techniques governing API particle properties and the processes that dictate the success of drug reception and tablet compression.

The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.

Drug Formulation and Delivery are changing rapidly, and the pace of change is expected to accelerate in the coming years

We had the pleasure of speaking with the Senior Human Factors Engineer at F. Hoffmann La-Roche about human factors and patient centricity in drug development

Biomanufacturing Digital Workshop hosted by Advanced Instruments

Moderator: Peter Dobson, Professor, University of Oxford
Panellists: Dimitrios Lamprou, Reader in Pharmaceutical Engineering, Queen’s University Belfast & David Brayden, Professor Of Advanced Drug Delivery, University College Dublin

Hovik Gukasyan, Associate Director, Early Development Formulation and Physical Chemistry, Allergan

Jonas Fast, Principal Scientist, Pharmaceutical Development at Roche. Date of Congress: 22nd - 23rd April 2020

Finn Bauer, Head of Solid Formulations R&D, Merck